Showing results (1-10 of 194) with videos related to
Sort By:
Pageof 20
Journal of Cardiac Failure|October 18, 2001
Inotropes and beta-blockers: is there a need for new guidelines?M R Bristow, S F Shakar, J V Linseman, et al.Current Cardiology Reports|April 18, 2001
Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agentsS F Shakar, M R BristowThe Annals of Pharmacotherapy|January 12, 2000
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilolJ Lindenfeld, B D Lowes, M R BristowJournal of the American College of Cardiology|May 15, 1998
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failureS F Shakar, W T Abraham, E M Gilbert, et al.Journal of the American College of Cardiology|December 12, 2001
Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockersJ Lindenfeld, A D Robertson, B D Lowes, et al.Molecular Medicine (Cambridge, Mass.)|January 10, 2003
Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotypeW T Abraham, E M Gilbert, B D Lowes, et al.Clinical Cardiology|February 7, 2001
Inotropes in the beta-blocker eraB D Lowes, M A Simon, T O Tsvetkova, et al.Journal of Cardiac Failure|July 25, 2000
Beta-blockade in adriamycin-induced cardiomyopathyA Noori, J Lindenfeld, E Wolfel, et al.International Journal of Cardiology|December 18, 2001
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilolB D Lowes, T Tsvetkova, E J Eichhorn, et al.Clinical Cardiology|December 16, 1998
The role of third-generation beta-blocking agents in chronic heart failureM R Bristow, R L Roden, B D Lowes, et al.Pageof 20